miRNA-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting PDCD4

Molecules and Cells

Volumn 37, Issue 12, 2015, Pages 873-880

  Yang, Miao ^a   Liu, Ran ^a   Li, Xiajun ^a   Liao, Juan ^a   Pu, Yuepu ^a   Pan, Enchun ^a   Yin, Lihong ^a   Wang, Yi ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b Huaian Center for Disease Control and Prevention   (China)

Author keywords

Apoptosis; Esophageal cancer; MiR 183; PDCD4; Proliferation

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 183; PROGRAMMED CELL DEATH 4 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; APOPTOSIS REGULATORY PROTEIN; MIRN183 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER PATIENT; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; G1 PHASE CELL CYCLE CHECKPOINT; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; MICROARRAY ANALYSIS; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DNA MICROARRAY; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA-BINDING PROTEINS;

EID: 84926611941     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2014.0147     Document Type: Article

References (45)

1. Achille, A., Biasi, M.O., Zamboni, G, Bogina, G, Magalini, A.R., Pederzoli, P., Perucho, M., and Scarpa, A. (1996). Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res. 56, 3808-3813.
2. Bieche, I., Champeme, M.H., Matifas, F., Hacene, K., Callahan, R., and Lidereau, R. (1992). Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339, 139-143.
3. Borel, C., and Antonarakis, S.E. (2008). Functional genetic variation of human miRNAs and phenotypic consequences. Mamm. Genome 19, 503-509.
4. Calin, GA., and Croce, C.M. (2006). MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866.
5. Corcoran, M.M., Mould, S.J., Orchard, J.A., Ibbotson, R.E., Chapman, R.M., Boright, A.P, Platt, C., Tsui, L.C., Scherer, S.W., and Oscier, D.G (1999). Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations. Oncogene 18, 6271-6277.
6. Dubecz, A., Gall, I., Solymosi, N., Schweigert, M., Peters, J.H., Feith, M., and Stein, H.J. (2012). Temporal trends in long-term survival and cure rates in esophageal cancer: a seer database analysis. J. Thorac. Oncol. 7, 443-447.
7. Eto, K., Goto, S., Nakashima, W., Ura, Y., and Abe, S.I. (2012). Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA. Cell Death Differ. 19, 573-581.
8. Fang, L., Du, W.W., Yang, W.N., Rutnam, Z.J., Peng, C., Li, H.R., O’Malley, Y.Q., Askeland, R.W., Sugg, S., Liu, M.Y, et al. (2012). MiR-93 enhances angiogenesis and metastasis by targeting LATS2. Cell Cycle 11, 4352-4365.
9. Fassan, M., Cagol, M., Pennelli, G, Rizzetto, C., Giacomelli, L., Battaglia, G., Zaninotto, G, Ancona, E., Ruol, A., and Rugge, M. (2010). Programmed cell death 4 protein in esophageal cancer. Oncol. Rep. 24, 135-139.
10. Fassan, M., Realdon, S., Pizzi, M., Balistreri, M., Battaglia, G., Zaninotto, G, Ancona, E., and Rugge, M. (2012). Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. Dis. Esophagus 25, 263-268.
11. Frankel, L.B., Christoffersen, N.R., Jacobsen, A., Lindow, M., Krogh, A., and Lund, A.H. (2008). Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283, 1026-1033.
12. Gaur, A.B., Holbeck, S.L., Colburn, N.H., and Israel, M.A. (2011). Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 13, 580-590.
13. Guo, X., Li, W., Wang, Q., and Yang, H.S. (2011). AKT activation by Pdcd4 knockdown up-regulates cyclin D1 expression and promotes cell proliferation. Genes Cancer 2, 818-828.
14. Guo, P., Huang, Z.L., Yu, P., and Li, K. (2012). Trends in cancer mortality in China: an update. Ann. Oncol. 23, 2755-2762.
15. Han, Y., Chen, J., Zhao, X., Liang, C., Wang, Y, Sun, L., Jiang, Z., Zhang, Z., Yang, R., Li, Z., et al. (2011). MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6, e18286.
16. He, J., and Chen, W. (2012). Chinese Cancer Registry Annual Report (Beijing, China: Military Medical Sciences Press).
17. Hu, Y, Correa, A.M., Hoque, A., Guan, B., Ye, F., Huang, J., Swisher, S.G., Wu, T.T., Ajani, J.A., and Xu, X.C. (2011). Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 128, 132-143.
18. Hvid-Jensen, F., Pedersen, L., Drewes, A.M., Sorensen, H.T., and Funch-Jensen, P. (2011). Incidence of adenocarcinoma among patients with Barrett’s esophagus. N. Engl. J. Med. 365, 1375-1383.
19. Jiang, Y., Zhang, S.H., Han, G.Q., and Qin, C.Y (2010). Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma. Biomed. Pharmacother. 64, 424-429.
20. Koo, S.H., Ihm, C.H., Kwon, K.C., Park, J.W., Kim, J.M., and Kong, G. (2001). Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet. Cytogenet. 130, 22-28.
21. Kwong, D., Lam, A., Guan, X., Law, S., Tai, A., Wong, J., and Sham, J. (2004). Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: Gain of 12p predicts poor prognosis after surgery. Hum. Pathol. 35, 309-316.
22. Lankat-Buttgereit, B., and Goke, R. (2009). The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol. Cell 101, 309-317.
23. Li, G.R., Luna, C., Qiu, J.M., Epstein, D.L., and Gonzalez, P. (2010a). Targeting of integrin p1 and kinesin 2a by microRNA 183. J. Biol. Chem. 285, 5461-5471.
24. Li, J., Fu, H., Xu, C., Tie, Y, Xing, R., Zhu, J., Qin, Y., Sun, Z., and Zheng, X. (2010b). miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10, 354.
25. Lin, Y, Totsuka, Y, He, Y., Kikuchi, S., Qiao, Y, Ueda, J., Wei, W., Inoue, M., and Tanaka, H. (2013). Epidemiology of esophageal cancer in Japan and China. J. Epidemiol. 23, 233-242.
26. ΔΔCtmethod. Methods 25, 402-408.
27. Ma, G., Zhang, H., Dong, M., Zheng, X.Y, Ozaki, I., Matsuhashi, S., and Guo, K.J. (2013). Downregulation of programmed cell death 4 (PDCD4) in tumorigenesis and progression of human digestive tract cancers. Tumor Biol. 34, 3879-3885.
28. Matsuhashi, S., Hamajima, H., Xia, J.H., Zhang, H., Mizuta, T., Anzai, K., and Ozaki, I. (2014). Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells. Cell. Signal. 26, 603-610.
29. Patil, V.S., Zhou, R., and Rana, T.M. (2014). Gene regulation by non-coding RNAs. Crit. Rev. Biochem. Mol. Biol. 49, 16-32.
30. Reis, P.P., Tomenson, M., Cervigne, N.K., Machado, J., Jurisica, I., Pintilie, M., Sukhai, M.A., Perez-Ordonez, B., Grenman, R., Gilbert, R.W., et al. (2010). Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma. Mol. Cancer 9, 238.
31. Salic, A., and Mitchison, T.J. (2008). A chemical method for fast and sensitive detection of DnA synthesis in vivo. Proc. Natl. Acad. Sci. USA 105, 2415-2420.
32. Santhanam, A.N., Baker, A.R., Hegamyer, G., Kirschmann, D.A., and Colburn, N.H. (2010). Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 29, 3921-3932.
33. Sarver, A.L., Li, L.H., and Subramanian, S. (2010). MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 70, 9570-9580.
34. Shibahara, K., Asano, M., Ishida, Y, Aoki, T., Koike, T., and Honjo, T. (1995). Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166, 297-301.
35. Tanaka, H., Sasayama, T., Tanaka, K., Nakamizo, S., Nishihara, M., Mizukawa, K., Kohta, M., Koyama, J., Miyake, S., Taniguchi, M., et al. (2013). MicroRNA-183 upregulates HiF-1 alpha by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells. J. Neuro-Oncol. 111, 273-283.
36. Thomson, D.W., Bracken, C.P., and Goodall, G.J. (2011). Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845-6853.
37. Ueno, K., Hirata, H., Shahryari, V., Deng, G., Tanaka, Y, Tabatabai, Z.L., Hinoda, Y, and Dahiya, R. (2013). microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br. J. Cancer 108, 1659-1667.
38. Wang, W., Zhao, J., Wang, H., Sun, Y, Peng, Z., Zhou, G., Fan, L., Wang, X., Yang, S., Wang, R., et al. (2010). Programmed cell death 4 (PDCD4) mediates the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by down-regulation of FLIP expression. Exp. Cell Res. 316, 2456-2464.
39. Wei, N., Liu, S.S., Chan, K.K.L., and Ngan, H.YS. (2012). Tumour suppressive function and modulation of programmed Cell Death 4 (PDCD4) in ovarian cancer. PLoS One 7, e30311.
40. Yang, M., Liu, R., Sheng, J.Y, Liao, J., Wang, Y, Pan, E.C., Guo, W., Pu, Y.P., and Yn, L.H. (2013). Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol. Rep. 29, 169-176.
41. Zhang, H., OzakiZ, I., Mizuta, T., Hamajima, H., Yasutake, T., Eguchi, Y, Ideguchi, H., Yamamoto, K., and Matsuhashi, S. (2006). Involvement of programmed cell death 4 in transforming growth factor-beta 1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25, 6101-6112.
42. Zhang, S.H., Li, J.F., Jiang, Y., Xu, Y.J., and Qin, C.Y (2009). Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells. J. Exp. Clin. Cancer Res. 28, 71.
43. Zhang, X., Wang, X.Y., Song, X.G., Liu, C.M., Shi, Y.Y., Wang, Y.K., Afonja, O., Ma, C.H., Chen, Y.H.H., and Zhang, L.N. (2010). Programmed cell death 4 enhances chemosensitivity of ovarian cancer cells by activating death receptor pathway in vitro and in vivo. Cancer Sci. 101, 2163-2170.
44. Zhao, H.E., Guo, M.J., Zhao, GY., Ma, Q., Ma, B.A., Qiu, X.C., and Fan, Q.Y (2012). miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells. Int. J. Mol. Med. 30, 1013-1020.
45. Zhu, J.F., Feng, Y.P., Ke, Z.F., Yang, Z., Zhou, J.Y, Huang, X.R., and Wang, L.T. (2012). Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am. J. Pathol. 180, 2440-2451.